Allspring Global Investments
NBIX icon

Allspring Global Investments’s Neurocrine Biosciences NBIX Stock Holding History

Allspring Global Investments’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1M Sell
332,408
-7,024
-2% -$932K 0.07% 312
2025
Q4 		$47.7M Sell
339,432
-43,009
-11% -$6.23M 0.08% 296
2025
Q3 		$52.4M Sell
382,441
-65,459
-15% -$8.87M 0.08% 272
2025
Q2 		$57.3M Buy
447,900
+60,094
+15% +$6.89M 0.1% 255
2025
Q1 		$41.5M Sell
387,806
-92,759
-19% -$11.8M 0.07% 330
2024
Q4 		$66.2M Sell
480,565
-209,421
-30% -$25.9M 0.11% 226
2024
Q3 		$79.5M Sell
689,986
-20,614
-3% -$2.83M 0.12% 201
2024
Q2 		$97.8M Buy
710,600
+203,934
+40% +$28M 0.16% 146
2024
Q1 		$69.9M Buy
506,666
+96,563
+24% +$13.2M 0.11% 241
2023
Q4 		$54M Buy
410,103
+184,660
+82% +$21.3M 0.09% 292
2023
Q3 		$25.4M Sell
225,443
-144,161
-39% -$15.2M 0.05% 487
2023
Q2 		$34.9M Buy
369,604
+31,590
+9% +$3.09M 0.06% 443
2023
Q1 		$34.2M Sell
338,014
-158,179
-32% -$16.5M 0.06% 441
2022
Q4 		$59.3M Sell
496,193
-42,846
-8% -$5.02M 0.1% 269
2022
Q3 		$57.3M Buy
539,039
+426,675
+380% +$43.3M 0.1% 250
2022
Q2 		$11M Sell
112,364
-90,391
-45% -$8.34M 0.02% 755
2022
Q1 		$19M Sell
202,755
-2,311
-1% -$196K 0.02% 676
2021
Q4 		$17.5M Buy
+205,066
New +$18.9M 0.02% 746

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's NBIX Position: Q1 2026 in Review

Allspring Global Investments reduced its Neurocrine Biosciences (NBIX) stake by 2.1% in Q1 2026, selling an estimated $932K and leaving 332,408 shares worth $44.1M. The position accounts for 0.07% of the portfolio, ranked #312.

Allspring Global Investments first reported a position in NBIX in Q4 2021 and has held it in 18 quarters since. The position peaked at $97.8M in Q2 2024. 696 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Allspring Global Investments held 332,408 shares of Neurocrine Biosciences worth $44.1M as of Q1 2026.
  • Allspring Global Investments sold 7,024 Neurocrine Biosciences shares in Q1 2026, an estimated $932K.
  • Neurocrine Biosciences made up 0.07% of Allspring Global Investments's portfolio in Q1 2026, its #312 holding.
  • Allspring Global Investments first reported a position in Neurocrine Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Neurocrine Biosciences position peaked at $97.8M in Q2 2024.
  • 696 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.